Article citationsMore>>

Ferguson, M.W., Duncan, J., Bond, J., Bush, J., Durani, P., So, K., Taylor, L., Chantrey, J., Mason, T., James, G., Laverty, H., Occleston, N.L., Sattar, A., Ludlow, A. and O’Kane, S. (2009) Prophylactic Administration of Avotermin for Improvement of Skin Scarring: Three Double-Blind, Placebo-Controlled, Phase I/II Studies. Lancet, 373, 1264- 1274.
http://dx.doi.org/10.1016/S0140-6736(09)60322-6

has been cited by the following article:

• TITLE: Clinical Use of Growth Factors in the Improvement of Skin Wound Healing

  AUTHORS: Sarita Mac Cornick, Silvana Aparecida Alves Corrêa de Noronha, Verônica Chominski, Samuel Marcos Ribeiro de Noronha, Lydia Masako Ferreira, Alfredo Gragnani

  KEYWORDS: Growth Factors, Wound Healing, Wound and Injuries, Keloid, Skin

  JOURNAL NAME: Open Journal of Clinical Diagnostics, Vol.4 No.4, December 1, 2014

  ABSTRACT: To discuss the normal mechanism of wound healing (WH), the role of growth factors (GF) in prec-linical and clinical studies and its importance in the healing of abnormal wound therapy. For search, we used the PUBMED and LILACS database, and the following descriptors: skin, wound healing, growth factor and clinical trials. We also prioritized the analysis of the Clinical Trials in the previous 10 years. Although there are many studies being conducted in the pre-clinical phase, we see that there are few studies in the clinical phase. 274 studies were identified, and 58 were selected. After tissue injury, repair occurs through coordinated biological actions that are healing. The importance of the study of healing in the skin is not only because of its anatomical location, easy access and exposure, but also because of its vital function. There is accumulating evidence that the process of healing after injury may be mediated by several GF. However, may this class of molecules even act effectively on the clinical response of this pathological condition? Many preclinical studies (in vitro and in vivo) reinforce the importance and efficacy of GF in the regeneration of damaged skin. Furthermore, recent studies have reported the use in adjuvant or not, of GF in clinical treatment to improve WH in humans. Therefore, we conclude that it seems to be effective by the use of GF in adjuvant or not in WH. However, it still seems to be necessary to carry out more clinical trials in phase I and II.